| Sucralfate | SUCRALFATE | Preferred Pharmaceuticals Inc | a434bf8f-cc60-4d84-a9a4-61c3ff6b700e | 2026-01-21 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | AvKARE | 0909acc5-c746-17fb-e063-6394a90a677f | 2026-01-19 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | Exact identifier unii: O8232NY3SJ |
| Sucralfate oral suspension | SUCRALFATE | Glenmark Pharmaceuticals Inc., USA | 1e595c2a-edd0-43f7-a2db-69553b9557d9 | 2026-01-06 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | f3095db3-fd02-873c-e053-2a95a90a5b1f | 2026-01-01 | Adverse reactions | Exact identifier application number: NDA018333 ndc (package): 51655-475-52 ndc (product): 51655-475 rxcui: 314234 spl id: 490f38ea-fc45-7aa2-e063-6294a90a9f1c spl set id: f3095db3-fd02-873c-e053-2a95a90a5b1f unii: XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | TruPharma, LLC | 7d441128-45d2-4bf2-817b-665784992e90 | 2025-12-29 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | Exact identifier unii: O8232NY3SJ |
| Sucralfate | SUCRALFATE | Northwind Health Company, LLC | 464bf611-4dbb-4707-b9dd-39ca178ed4bf | 2025-12-26 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Redpharm Drug | 3251e156-4c52-63b3-e063-6294a90a9a95 | 2025-12-18 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvKARE | c019bf24-8273-8d2f-e053-2a95a90aec98 | 2025-12-03 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE ORAL | AvPAK | e78ef7d4-faa7-aebf-e053-2995a90a6f84 | 2025-12-03 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Torrent Pharmaceuticals Limited | dc361b46-fda4-4b0b-9950-e8885ba5b084 | 2025-08-21 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Mylan Institutional Inc. | 989ca8a8-3ad6-4ee4-aa9c-eed731828753 | 2025-07-22 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Kesin Pharma Corporation | 36d940f2-207b-68c5-e063-6294a90a6b4a | 2025-07-01 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | NCS HealthCare of KY, LLC dba Vangard Labs | d67dcaad-56c1-4e77-a0c8-655970808414 | 2025-06-13 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Bryant Ranch Prepack | a73010fb-960c-4567-8ab1-6d902fee2c14 | 2025-06-02 | Adverse reactions | Exact identifier application number: NDA018333 ndc (package): 71335-2637-6 ndc (package): 71335-2637-7 ndc (package): 71335-2637-2 ndc (package): 71335-2637-9 ndc (package): 71335-2637-1 ndc (package): 71335-2637-8 ndc (package): 71335-2637-3 ndc (package): 71335-2637-4 ndc (package): 71335-2637-0 ndc (product): 71335-2637 rxcui: 314234 spl id: dc7f253b-f40a-4774-8456-1d383fb35b0c spl set id: a73010fb-960c-4567-8ab1-6d902fee2c14 unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | ATLANTIC BIOLOGICALS CORP. | e5073597-ac51-4e7c-a9dc-7695773a01f1 | 2025-05-27 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | Richmond Pharmaceuticals, Inc. | 7ac10c3f-9d50-4702-900c-41075ac6f896 | 2025-05-23 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| sucralfate | SUCRALFATE | Bryant Ranch Prepack | abc44549-ac41-4aef-9b15-2ba536e1555f | 2025-05-09 | Warnings, Adverse reactions | Exact identifier unii: XX73205DH5 |
| Sucralfate | SUCRALFATE | NuCare Pharmaceuticals, Inc. | 31a7dcd0-e677-249a-e063-6294a90a75f6 | 2025-03-19 | Adverse reactions | Exact identifier rxcui: 314234 unii: XX73205DH5 |